Core Viewpoint - Health 160 (02656) has seen a significant increase in stock price, rising over 256% from its IPO price of HKD 11.89 to a peak of HKD 42.34, indicating strong market interest and confidence in the company's business model and growth potential [1] Company Overview - Health 160 is an experienced wholesale distributor of pharmaceutical and health products in China, as well as a leading provider of integrated digital healthcare services [1] - The company offers a wide range of pharmaceutical health products and comprehensive digital healthcare solutions [1] Digital Healthcare Platform - Health 160 operates an online healthcare service platform that connects various stakeholders in the healthcare industry, enhancing the overall healthcare ecosystem [1] - As of March 31, 2025, the platform has connected over 44,600 healthcare institutions, including more than 14,400 hospitals (of which 3,430 are tertiary hospitals) and over 30,200 grassroots healthcare institutions [1] - Among the partnered healthcare institutions, over 6,800 private entities provide consumer medical services such as dental, ophthalmology, and health check-up services through the platform [1]
健康160盘中涨超8% 再创历史新高 上市月余较招股价已涨超256%